Etubics' Grant

Etubics raised a round of funding on August 24, 2007. Investors include National Institute of Allergy and Infectious Diseases.

Etubics Corporation is a clinical stage biotechnology company focused on developing immunotherapeutics for the treatment of cancer and vaccines against infectious diseases. The Company has a pipeline …

Articles about Etubics' Grant: